Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Park, J. H., Nikiforow, S., Kim, S., Hu, Z.-H., Moskop, A., Ahmed, S., Bilal Abid, M., Badar, T., Bredeson, C., Brown, V., Cairo, M. S., Díaz, M., Dholaria, B., Ganguly, S., Grover, N. S., Hanna, R., Hematti, P., Kohorst, M. A., Lazarus, H., … Perales, M.-A. (2021). Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Blood, 138(Supplement 1), 3880–3880. https://doi.org/10.1182/blood-2021-148652
Authors:
Jae H. Park
Sarah Nikiforow
Soyoung Kim
Zhen‐Huan Hu
Amy Moskop
Sairah Ahmed
Muhammad Bilal Abid
Talha Badar
Christopher Bredeson
Valerie I. Brown
Mitchell S. Cairo
Miguel Ángel Díaz
Bhagirathbhai Dholaria
Siddhartha Ganguly
Natalie S. Grover
Rabi Hanna
Peiman Hematti
Mira A. Kohorst
Hillard M. Lazarus
Lazaros J. Lekakis
Frederick L. Locke
Hemant S. Murthy
Alberto Mussetti
Michael A. Pulsipher
Muna Qayed
Ran Reshef
David A. Rizzieri
María Queralt Salas
Bipin B. Savani
Akshay Sharma
Kirk R. Schultz
Monica S. Thakar
Cameron J. Turtle
Jean A. Yared
John L. Wagner
Xianmiao Qiu
Marcelo C. Pasquini
Miguel-Ángel Perales
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-148652
DOI:
10.1182/blood-2021-148652
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: